NON-HORMONAL TREATMENT OF PATIENTS WITH BENIGN BREAST DYSPLASIA
S.A. Levakov, M.G. Kaviladze, N.A. Sheshukova, A.Z. Gelashvili
For quotation:
Levakov S.A., Kaviladze M.G., Sheshukova N.A., Gelashvili A.Z. Non-hormonal treatment of patients
with benign mammary dysplasia. The origin of life. 2022; (1):24–27.
DOI 10.46393/27826384_2022_1_24
Annotation:
Benign mammary dysplasia is diagnosed in approximately 50% of women of reproductive age and perimenopause and represents a spectrum of diseases characterized by the presence of an abnormal picture with various instrumental imaging methods, palpable formations and changes in the structure of the mammary glands identified as a result of physical examination. Taking into account the high risk of malignancy in benign dysplasia, it is necessary to develop drugs that have antiproliferative activity against pathological mammary gland cells and their integration into the treatment regimen for patients to prevent possible progression
of these diseases. Indole-3-carbinol (I3C) is a phytonutrient, or plant substance, produced by the breakdown of the glucosinolate indole-3-ylmethylglucosinolate, found in cruciferous vegetables. Our study is devoted to assessing the effectiveness of the use of the non-hormonal drug Indinol Forto®, containing the pharmaceutical substance indole carbinol, in patients with benign mammary dysplasia.
Magazine “The Origin of Life” No. 1_2022
https://drive.google.com/file/d/1WguxpEe8JUthfcz4nyvms_ioW9vKH1wG/view
S.A. Levakov, M.G. Kaviladze, N.A. Sheshukova, A.Z. Gelashvili
For quotation:
Levakov S.A., Kaviladze M.G., Sheshukova N.A., Gelashvili A.Z. Non-hormonal treatment of patients
with benign mammary dysplasia. The origin of life. 2022; (1):24–27.
DOI 10.46393/27826384_2022_1_24
Annotation:
Benign mammary dysplasia is diagnosed in approximately 50% of women of reproductive age and perimenopause and represents a spectrum of diseases characterized by the presence of an abnormal picture with various instrumental imaging methods, palpable formations and changes in the structure of the mammary glands identified as a result of physical examination. Taking into account the high risk of malignancy in benign dysplasia, it is necessary to develop drugs that have antiproliferative activity against pathological mammary gland cells and their integration into the treatment regimen for patients to prevent possible progression
of these diseases. Indole-3-carbinol (I3C) is a phytonutrient, or plant substance, produced by the breakdown of the glucosinolate indole-3-ylmethylglucosinolate, found in cruciferous vegetables. Our study is devoted to assessing the effectiveness of the use of the non-hormonal drug Indinol Forto®, containing the pharmaceutical substance indole carbinol, in patients with benign mammary dysplasia.
Magazine “The Origin of Life” No. 1_2022
https://drive.google.com/file/d/1WguxpEe8JUthfcz4nyvms_ioW9vKH1wG/view
